Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000031.xml
Download PDF
Klin Monbl Augenheilkd 2019; 236(04): 578-580
DOI: 10.1055/a-0800-8066
DOI: 10.1055/a-0800-8066
Der interessante Fall
Regression of Optic Disc Neovascularization (NVD) in a Patient with Behçetʼs Disease Treated with Oral Corticosteroids and Adalimumab (ADA)
Regression der Papillenneovaskularisation (NVD) bei einem Patienten mit Behçet-Krankheit unter Behandlung mit oralen Kortikosteroiden und AdalimumabFurther Information
Publication History
received 19 September 2018
accepted 08 November 2018
Publication Date:
07 January 2019 (online)
Background
Optic disc and retinal neovascularization are uncommon but severe complications of Behçetʼs disease, which, as a result of occlusive retinal vasculitis, may lead to visual impairment and lacks standardized treatment.
-
References
- 1 Dick AD, Rosenbaum JT, Al-Dhibi HA. et al. Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis. Fundamentals of Care for UveitiS (FOCUS) initiative. Ophthalmology 2018; 125: 757-773
- 2 Ming S, Xie K, He H. et al. Efficacy and safety of adalimumab in the treatment of non-infectious uveitis: a meta-analysis and systematic review. Drug Des Devel Ther 2018; 12: 2005-2016
- 3 Tugal-Tutkun I, Onal S, Altan-Yaycioglu R. et al. Neovascularization of the optic disc in Behçetʼs disease. Jpn J Ophthalmol 2006; 50: 256-265
- 4 Kawaguchi T, Sugita S, Yamada Y. et al. Regression of optic disc neovascularization in patients with Behçetʼs uveoretinitis after infliximab therapy. J Ocul Pharmacol Ther 2010; 26: 627-630